Alan C. Cheng

Nature Biotechnology · 2007

A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Whom Alan C. Cheng trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Michelle Arkin
  2. J. Wells
  3. M. Schachter

Who trusts Alan C. Cheng overall

  1. David K. Johnson
  2. Kevin Bleakley
  3. Yoshihiro Yamanishi
  4. John Karanicolas
  5. Yunan Luo
  6. J. Wells
  7. Mehmet Gönen

Papers from Alan C. Cheng's perspective

Ordered by how strongly the researchers Alan C. Cheng trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Implications of protein flexibility for drug discovery
  2. The druggable genome (Nature reviews. Drug discovery)
  3. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
  4. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update (Fundamental & Clinical Pharmacology)
  5. Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
  6. In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 (Science)
  7. Structural Mechanism for Statin Inhibition of HMG-CoA Reductase (Science)
  8. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. (Journal of Medicinal Chemistry)
  9. Predicting druggable binding sites at the protein-protein interface.
  10. Protein–protein docking benchmark version 4.0 (Proteins: Structure, Function, and Bioinformatics)

Their papers